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This study aimed to examine the bidirectional relationship between psychotropic 
medication use and changes in leisure-time physical activity (LTPA) among a population 
cohort study. Phase 1 data were collected by mail surveys in 2000–2002 among 40–60-year-
old employees of the City of Helsinki, Finland, and phase 2 follow up survey was conducted 
in 2007. Based on self-report, the respondents were classified as inactive and active (≥14.75 
MET-hours/week) at the phases 1 and 2. Hazard ratios (HR) were calculated for subsequent 
(2007-10) psychotropic medication purchasing according to changes in physical activity 
(phases 1-2). Odds ratios (OR) for physical inactivity at phase 2 were calculated according to 
the amount of psychotropic medication between phases 1-2. Overall, 5361 respondents 
were included (mean age 50 years, 80% women). Compared with the persistently active, the 
persistently inactive, those decreasing and adopting LTPA had an increased risk for 
psychotropic medication. Only the persistently inactive remained at increased risk for 
psychotropic medication use, following the adjustment for prior psychotropic medication 
use. Compared with those having no medication, the risk for physical inactivity increased as 
the psychotropic medication increased. Our data suggest that physical activity has an 
important role in maintaining wellbeing and reducing psychotropic medication usage. 
 
Key words: exercise, physical inactivity, mental health, psychotropic medication 
 
 
1. Introduction 
Physical activity has a range of benefits for health and well-being (Penedo et al., 2005). 
Conversely, physical inactivity is attributed as the fourth leading cause of preventable 
mortality in the world, largely due to the increased cardiovascular risk profile (Kohl et al., 
2012). Recently, interest has begun regarding the beneficial influence of physical activity on 
promoting good mental health. For instance, Mammen and Faulkner (2013) found in a 
systematic review that physical activity has a protective effect from future depression. The 
evidence base for physical activity and good mental health is increasing, with more and 
more interest developing to see if physical activity can prevent the onset of poor mental 
health outcomes. Moreover, in those with a pre-existing mental illness, exercise (a 
structured form of physical activity) has been demonstrated to improve depressive 
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symptoms (Bridle et al., 2012; Rosenbaum et al., 2014; Carter et al., 2015, Schuch et al., 
2016) and symptoms of schizophrenia including cognition (Firth et al., 2015, Firth et al., 
2016). 
 
While promoting physical activity and exercise are gaining credibility, 
pharmacotherapy remains the cornerstone for the multidisciplinary treatment of many 
people with mental health problems. In the past decade, the use of psychotropic medication 
has substantially increased, partly owing to the regulatory broadening of the indications for 
several psychotropic medications (Mojtabai et al., 2010; Wu et al., 2013). Psychotropic 
medication is typically effective in alleviating mental health symptoms but also often has 
various side effects. In particular antipsychotics and to a lesser extent antidepressants and 
mood stabilizers, are associated with an increased risk for several chronic physical diseases, 
obesity, diabetes and cardio-metabolic diseases (Correll et al., 2015; Vancampfort et al., 
2015). Higher dosages, polypharmacy, and treatment of vulnerable (e.g., old or young) 
individuals are associated with greater absolute (elderly) and relative (youth) risk. To what 
degree medication-specific and patient-specific risk factors interact, and how adverse 
outcomes can be minimized, allowing patients to derive maximum benefits from these 
psychotropic medications, requires adequate clinical attention and further research (De 
Hert at al., 2011). For example, since it is known that physical inactivity is an important risk 
factor for a wide range of chronic diseases and premature mortality (Kodama et al., 2009; 
Lahti et al., 2014), research is required to investigate whether psychotropic medication is a 
risk factor for lower physical activity and therefore future increased risk of cardiovascular 
disease outcomes. Surprisingly, no longitudinal, population cohort studies have considered 
whether higher levels of physical activity are associated with lower psychotropic medication 
use and if psychotropic medication is associated with less physical activity in the future. 
Understanding this relationship may have potential importance for mental health 
promotion, in addition to help identify if those in receipt of psychotropic medication are at 
risk of declining physical activity and therefore more at risk of cardio-metabolic diseases.  
Given the aforementioned, we set out to explore the bidirectional relationship 
between (a) changes in leisure-time physical activity and subsequent psychotropic 
medication use, and (b) psychotropic medication use and subsequent physical inactivity 
using data from the Helsinki Health Study (Lahelma et al., 2013). 
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2. Methods 
2.1 Study population 
The data from the current study were collected as part of the Helsinki Health Study. The 
Helsinki Health Study cohort was set up to enable longitudinal studies on the social and 
work related determinants of health and well-being, making use of self-reported as well as 
objective register data. The target population is the staff of the City of Helsinki, Finland. 
(Lahelma et al., 2013). Follow-up survey data were collected from midlife employees of the 
City of Helsinki, Finland, at two time points: phase 1 (2000-2002) and phase 2 (2007) 
(Lahelma et al., 2013). Phase 1 data were collected by postal questionnaire surveys in 2000, 
2001 and 2002. Questionnaires were mailed to all employees of the City of Helsinki who 
reached the age of 40, 45, 50, 55 and 60 during each survey year. The study has been 
approved by the ethics committees of the Department of Public Health, University of 
Helsinki and the health authorities of the City of Helsinki.  
 
2.2 Leisure-time physical activity 
The respondents were asked about their average weekly hours of leisure-time physical 
activity (commuting included) within the previous 12 months. Four intensity grades were 
given: walking, brisk walking, jogging, and running, or their equivalent activities. 
Approximate metabolic equivalents (MET-hours per week) were calculated for the volume 
of weekly leisure time physical activity. MET-hours per week were calculated by multiplying 
the time spent physically active by the estimated MET value of each four intensity grades 
(Kujala et al., 1998) and adding the four values together (Ainsworth et al., 2000). 
Respondents were classified as inactive according to the lowest tertile (under 14.75 MET-
hours/week) or active when above this threshold (at least 14.75 MET-hours/week (Lahti et 
al., 2014). These two groups at the phases 1-2 yielded four groups describing persistency 
and changes over time in leisure-time physical activity.  
 
2.3 Psychotropic medication  
The purchases of prescribed psychotropic medication were classified according to the 
Anatomical Therapeutic Chemical (ATC) classification system (WHO 2009). Any psychotropic 
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medication included ATC codes N05 and N06 except medication for dementia N06D. The 
follow-up started on the day of returning the phase 1 questionnaire and continued for the 
entire year 2010. For examining the two separate research questions, psychotropic 
medication purchases were calculated separately for the period between phases 1-2 and 
the period after phase 2. For the first period (phases 1-2), the amount of psychotropic 
medication was calculated as defined daily doses (DDD’s) i.e. the assumed medication dose 
per day used for its main indication. The DDD’s were classified into four groups according to 
tertiles of medication use: 1. No medication, 2. Low  <100 DDD’s, 3. Medium =100-700 
DDD’s and 4. High >700 DDD’s. For the second period, the time to the first purchase was 
examined. 
 
2.4 Covariates 
Covariates included age, gender, socioeconomic position (SEP), smoking, binge drinking, 
body mass index (BMI) and physical functioning. The information on socioeconomic position 
(SEP) was taken from the phase 1 survey including four occupational social classes: 
managers (managerial and administrative work) and professionals (e.g. teachers and 
doctors), semi-professionals (e.g. nurses and foremen), routine non-manual (e.g. child 
minders and assistant maids) and manual workers (e.g. transport and cleaning work) 
(Lahelma et al., 2013). Smoking status change between phases 1 and 2 was classified into 
four groups: 1. non-smokers, 2. became non-smokers, 3. became smokers and 4. smokers. 
Similar procedure was applied for binge drinking (≥ 6 portions of alcohol more than once a 
month) (Paljärvi et al., 2009), being overweight (BMI ≥ 25kg/m2) (Svärd et al., 2016) and 
lowered physical functioning (under the maximum score of 100) measured by the physical 
functioning subscale of the Short-Form (SF-36) health questionnaire (Ware, 2000). 
 
2.5 Statistical methods 
For estimating the effect of changes in physical activity (phases 1-2) on the risk of 
subsequent psychotropic medication use we used Cox regression analysis to calculate 
hazard ratios (HR) and their 95% confidence intervals (95% CI) for first psychotropic 
medication purchase during the follow-up period 2007-2010. The persistently active group 
was used as the reference group. In model 1 age and gender were adjusted for. In model 2 
covariates in model 1 and prior psychotropic medication (phases 1-2) were adjusted. In 
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model 3 covariates in model 1 and physical functioning were adjusted. In model 4 covariates 
in model 2 and physical functioning, socioeconomic position, smoking, binge drinking and 
body mass index were adjusted. The proportional hazards assumption was confirmed using 
Schoenfeld residuals (Schoenfeld, 1982).  
For estimating the effect of psychotropic medication use (phases 1-2) on the risk for 
physical inactivity (phase 2) we calculated odds ratios (OR) and their 95% CI’s for physical 
inactivity according to the amount of psychotropic medication purchases. Psychotropic 
medication purchase groups were compared to those without medication purchases. In 
model 1 age and gender were adjusted for. In model 2 covariates in model 1 and physical 
functioning were adjusted for. In model 3 covariates in model 1 and physical inactivity 
(phase 1) were adjusted. In model 4 covariates in model 1 and socioeconomic position, 
smoking, binge drinking and body mass index were adjusted for. SPSS 23 statistical package 
was used. 
 
 
3. Results 
3.1. Study population 
The target population consisted of 13,346 employees. The response rates were 67% 
(n=8960) for phase 1 survey and 83% (n=7332) for the phase 2 survey. The questionnaire 
survey data were linked with the national register on prescribed, reimbursed psychotropic 
medication purchases obtained from the Social Insurance Institution of Finland (74% of the 
phase 1 respondents gave informed written consent for the linkages). According to our non-
response analyses, there were only minor differences between the survey respondents and 
non-respondents, although younger men and manual workers were slightly 
underrepresented among the respondents (Lahelma et al., 2013; Laaksonen et al., 2008). 
Not consenting to the data linkage showed even smaller differences than the survey non-
response (Lahelma et al., 2013; Laaksonen et al., 2008). There were missing data in some of 
the study variables (n=214). The analyses included 5,361 (80% women) respondents.  
Among the 5,361 participants (mean age 50 years) approximately 16% were 
persistently inactive from phase 1 to phase 2 and 53% were persistently active (Table 1). 
Approximately 16% moved from inactive to active and 14% from active to inactive. In 
comparison, we calculated the proportions among those who did not consent to the register 
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linkage (n=1533) which found only minor non-significant differences; persistent inactivity 
showed slightly more common (20%) and persistent activity less common (50%) than among 
the consenters. Among the study participants, those persistently active and those who 
became active tended to come less often from lower SEP groups (Table 1). In addition, they 
tended to be less often smokers and binge drinkers. There was also a tendency showing that 
those persistently active had less often overweight. Approximately 28% of the respondents 
had psychotropic medication between phases 1-2 and the persistently active tended to have 
less often high psychotropic medication use and more often no medication.  
 
3.2. The effect of changes in physical activity on the risk of psychotropic medication use 
During the 2.3 years follow-up after phase 2, 25% of the respondents received psychotropic 
medication, ranging from 21% among the persistently active to 32% among the persistently 
inactive (Table 2). Testing for interactions showed that the associations were similar for 
women and men (p=0.9). Compared with the persistently active, those persistently inactive 
(HR=1.61, 95%CI=1.40-1.85), those decreasing (HR=1.39, 95%CI=1.19-1.62) and those 
adopting (HR=1.19, 95%CI=1.02-1.39) physical activity had increased risk for the initiation of 
psychotropic medication in the age and gender adjusted model. Only the persistently 
inactive (HR=1.37, 95%CI=1.19-1.58) remained at increased risk for psychotropic medication 
use, when adjustment was made for prior psychotropic medication (Model 2). Similarly, 
adjusting for physical functioning attenuated the associations, whereas, additive adjustment 
for confounders had no effect.  
 
3.3. The effect of psychotropic medication use on the risk for physical inactivity 
Compared with those having no medication, the prevalence of physical inactivity at phase 2 
increased in a dose-response manner as the amount of psychotropic medication use 
increased, ranging from 28% among those with no medication to 41% among those in the 
highest third (>700 DDD’s) of medication use (Table 3). Testing for interactions showed that 
the associations were similar for women and men (p=0.2). In the age and gender adjusted 
model, compared to those without medication, those in the highest third of psychotropic 
medication purchases, had the highest risk for subsequent inactivity (OR=1.72, 95%CI=1.41-
2.10). Those in the middle (OR=1.42, 95%CI=1.16-1.72) and those in the lowest third 
(OR=1.24, 95%CI=1.02-1.50) had also significantly increased risk for inactivity. Adjusting for 
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physical functioning attenuated the associations and only the highest medication group 
remained at increased risk for physical inactivity (OR=1.45, 95%CI=1.18-1.77). Whereas 
adjusting for inactivity at phase 1 and other confounders had only slight attenuating effects.  
 
4. Discussion 
To the best of our knowledge the current study is the first to explore the longitudinal 
bidirectional relation between psychotropic medication use and changes in leisure-time 
physical activity. Our data show that persistently inactive people had an increased risk for 
the initiation of psychotropic medication compared with persistently active persons. 
Conversely, compared to those not in receipt of medication, the risk for subsequent physical 
inactivity increased in a dose-response manner as the amount of psychotropic medication 
increased. In summary, our results suggest a longitudinal inverse relationship between 
physical activity and mental health (expressed as psychotropic medication use). Therefore, 
the potential for physical activity to maintain and promote positive mental health and 
apparently reduce the need for psychotropic medication is important.   
A number of studies have previously reported that decreases in physical activity 
levels over time increases the risk of developing depression (Camacho et al., 1991; Carroll et 
al., 2010), and vice versa (Gudmundsson et al., 2015). Moreover increasing levels of physical 
activity can reduce the risk of subsequent depression (Ball et al., 2009; Brown et al., 2005), 
and even maintaining some physical activity is associated with a lower risk of depression 
compared to those who remain totally inactive (Wise et al., 2006). Given the importance of 
maintaining good mental health and viewing psychotropic medication as a last resort to 
treat a mental disorders, our data suggest that maintaining physical activity levels may have 
a protective effect from subsequent psychotropic medication use. This is encouraging, 
particularly given the multiple side effects associated with psychotropic medication (Correll 
et al., 2015). Overall, the findings from our study suggest that increasing and maintaining 
physical activity over time should be encouraged in order to reduce the risk of developing 
poor mental health and being prescribed psychotropic medication. An alternative 
explanation of our data might be that the physical (in)activity is actually a proxy for mental 
health symptoms. For instance, it could be hypothesized that higher level of mental health 
symptoms require psychotropic medication and may therefore be related to lower levels of 
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inactivity. Clearly, future longitudinal research is required to disentangle the relationships 
we observed and should attempt to ascertain the impact of mental health symptom 
severity. 
Different mechanisms for the protective role of physical activity on psychotropic 
medication use can be hypothesised. On a neurobiological front, a number of acute changes 
occur during and following bouts of physical activity, and several long-term adaptations are 
related to regular physical activity. For instance, physical activity has been found to 
normalize reduced levels of brain-derived neurotrophic factor and therefore has neuro-
protective or even neurotrophic effects (Szuzany et al., 2015). Animal studies have found 
physical activity-induced changes in the levels of different neurotransmitters such as 
dopamine (Clark et al., 2015), serotonin (Otsuka et al., 2016), glutamate (Real et al., 2010), 
and acetylcholine (Uchida et al., 2006), which relate to mood and beneficial effects on stress 
reactivity (e.g., the hypothalamus-pituitary-adrenal axis). Potential psychosocial 
mechanisms include social reinforcement, experience of mastery in dealing with mental 
health problems, shift of external to more internal locus of control, improved coping 
strategies, or physical activity as distraction (Daley, 2002; Fox, 1999).  
Conversely, our data suggest that psychotropic medication use (particularly among 
those with the highest DDD), is associated with future inactivity. Given the fact that 
psychotropic medication increases the risk of weight-gain and chronic physical diseases 
(Correll et al., 2015) and that physical activity may have a protective role in preventing such 
unwanted consequences (Rosenbaum et al., 2014), there is a need to develop appropriate 
future interventions to increase physical activity in this population. Previous research in 
people with recognised mental illnesses, such as depression (Stubbs et al., 2016) and 
schizophrenia (Vancampfort et al., 2015), have demonstrated that lower drop outs from 
physical activity are associated with supervision by qualified professional groups (e.g. 
physical therapists and/or exercise physiologists). Therefore, in those with particularly high 
psychotropic medication doses, interventions delivered by specialists may be required. 
Given the large numbers of people in receipt of psychotropic medication and the increased 
associated morbidity, investment in resources to increase physical activity in daily life for 
people receiving psychotropic medication may offer excellent value, both economically and 
from a mental and physical health perspective.  
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Whilst our results are novel and of interest, it is important that future prospective 
population cohort studies are conducted to confirm our findings. Future prospective cohort 
studies should if possible consider people across a spectrum of socioeconomic positions, 
both genders and attempt to disentangle the bidirectional relationship between different 
psychotropic agents. The latter will be particularly helpful to clinicians and those who 
prescribe medication. Moreover, future research should attempt to consider the impact of 
sedentary behaviour and capture this together with physical activity using appropriate 
objective methods such as accelerometers. Finally, future research should consider if 
physical activity prescription can prevent the need for psychotropic medication within a 
large pragmatic randomised control trial. Only under such circumstances will it be possible 
to address the question of causality in the associations we observed.  
 
4.1 Strength and limitations 
The current study has a number of strengths. We utilized a large cohort including both 
women and men exploring bidirectional associations between changes in leisure-time 
physical activity participation and psychotropic medication use. Next to this, we were able 
to control for a wide range of important covariates including age, gender, socioeconomic 
position, smoking, binge drinking, BMI and physical functioning. However, unmeasured and 
residual confounding is possible. The present findings need, however, be interpreted with 
caution as well because of some limitations of our data. Firstly, the participants were 
middle-aged public sector employees and 80% of them were women corresponding to the 
gender distribution of the target population and the municipal sector in Finland. Whilst the 
results are overrepresented by females, the associations we observed in our study were 
similar among women and men. Hence our data are not representative for the entire 
population, in particular for the most vulnerable groups for instance those being 
unemployed. Another limitation was the reliance on self-reported recall physical activity 
that lack validation, however, no single physical activity questionnaire has proven superior 
(van Poppel et al., 2010). Thirdly, non-response and attrition may be a problem in 
longitudinal cohort studies. In our study, the phase 1 response rate (67%) was acceptable 
and good for the phase 2 (83%). In addition, there was further attrition due to consenting to 
the register linkage. According to our non-response analyses e.g. the non-respondents were 
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somewhat younger and from lower occupational classes and had slightly more long sickness 
absences than the responders, however, the differences were small and thus the results are 
unlikely to be markedly biased (Lahelma et al., 2013; Laaksonen et al., 2008). In addition, we 
showed that those consenting and not consenting to the register linkage had similar 
patterns of leisure-time physical activity between phases 1-2, although physical inactivity 
was somewhat more common among the non-consenters. Due to attrition and the fact that 
all participants were initially employed the participants are a selected group i.e. healthier 
and physically more active than the general population and thus the results are probably 
conservative showing weaker associations than for general population (Li and Sung, 1999). 
The medication data came from national health register. They are likely to be 
accurate since the information is originally collected for administrative purposes and used 
as the basis for monetary reimbursements. However, the purchases of prescribed 
psychotropic medication may not be considered as a direct measure of mental health 
problems. Whilst psychotropic medication is primarily utilised to treat common mental 
disorders, the use of certain classifications, such as antidepressants, is increasing for other 
conditions such as pain and sleep problems. In addition, there is comorbidity between 
common mental disorders such as anxiety and depression (Scott et al., 2007) and 
antidepressants are also prescribed for anxiety disorders (Sihvo et al., 2006) and we do not 
know the specific mental disorders that these medications were prescribed for. Our 
previous analyses have, however, shown similar associations between leisure-time physical 
activity and use of antidepressants and sedatives (Lahti et al., 2013). Thus we chose to use 
any psychotropic medication in our analyses examining the bidirectional associations in a 
longitudinal setting. 
 
5. Conclusions 
We examined bidirectional relationship between physical activity and psychotropic 
medication and found that physical activity is associated with a reduced need for 
psychotropic medication after adjusting for pertinent confounders. Moreover, psychotropic 
medication use, particularly in high doses, is associated with less physical activity. Given 
these findings, our data suggest that physical activity has an important role in maintaining 
wellbeing and reducing the need for psychotropic medication.  
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Table 1. Description of study variables by leisure time physical activity change groups. 
    
Leisure-time  
physical activity 
Phase 1 Inactive Active Inactive Active  
Phase 2 Inactive  Inactive  Active  Active  All 
N (%)  911 (17) 728 (14) 864 (16) 2858 (53) 5361 
Women (%)  80 81 82 79 80 
Age (mean)  51 49 50 49 50 
Socioeconomic position (%)       
Manual workers   17 16 11 12 13 
Routine non-manuals   35 38 33 33 34 
Semi-professionals  18 19 21 21 20 
Managers/professionals  31 27 35 34 33 
Smoking (%)       
Smokers  21 21 15 13 16 
Became smokers  2 1 1 2 2 
Became non-smokers  7 7 7 5 6 
Non-smokers  69 71 77 81 77 
Binge drinking (%)       
Binge drinker a  19 19 15 14 16 
  
18 
18 
Became binge drinker  6 9 6 7 7 
Became non-binge drinker  7 6 5 6 6 
Non-binge drinker  68 67 74 73 71 
Body mass index (%)       
Overweight b  61 51 47 36 44 
Became overweight  9 13 10 10 10 
Became normal weight  5 3 5 4 4 
Normal weight  26 33 39 50 42 
Psychotropic medication 
Phases 1-2 (%) 
      
High (>700 DDD) c  13 11 8 7 9 
Medium (100-700 DDD)  11 11 11 8 9 
Low (< 100 DDD)  11 8 10 10 10 
No medication  66 67 72 75 72 
 Physical functioning (%)      
Sub-optimal functioning  72 62 56 42 52 
Became sub-optimal   11 15 16 17 16 
Became optimal   6 6 11 10 9 
Optimal functioning  11 15 17 31 23 
a ≥ 6 portions of alcohol more than once a month 
b ≥ 25kg/m2 
c Defined Daily Dose 
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Table 2. Hazard ratios (95% CI) and proportions (%) for any psychotropic medication 
purchase after phase 2 by leisure-time physical activity change groups. 
Leisure time 
physical activity 
Psychotropic 
medication 
Model 1 Model 2 Model 3 Model 4 
Phase 1 Phase 2 %     
Inactive Inactive 32 1.61  
(1.40-1.85) 
1.37  
(1.19-1.58) 
1.39  
(1.20-1.60) 
1.37 
(1.18-1.58) 
Active Inactive 29 1.39 
(1.19-1.62) 
1.14 
(0.98-1.34) 
1.24 
(1.06-1.45) 
1.15 
(0.98-1.35) 
Inactive Active 25 1.19  
(1.02-1.39) 
1.13  
(0.97-1.32) 
1.11  
(0.95-1.30) 
1.13  
(0.97-1.32) 
Active Active 21 1.00 1.00 1.00 1.00 
Model 1 adjusted for age and gender 
Model 2 Model 1 + psychotropic medication phases 1-2 
Model 3 Model 1 + physical functioning 
Model 4 Model 2 + physical functioning, socioeconomic position, binge drinking, smoking, 
BMI 
 
 
Table 3. Odds ratios (95% CI) and proportions (%) for physical inactivity (phase 2) by any 
psychotropic medication (phases 1-2).  
Psychotropic 
medication 
Inactive  
phase 2  
 Model 1 Model 2 Model 3 Model 4 
phases 1-2 (%)      
High  
>700 DDD 
41  1.72  
(1.41-2.10) 
1.45  
(1.18-1.77) 
1.65  
(1.33-2.03) 
1.53  
(1.25-1.87) 
Medium  
100-700 DDD 
36  1.42  
(1.16-1.72) 
1.20  
(0.98-1.46) 
1.32  
(1.07-1.63) 
1.33  
(1.09-1.63) 
Low  
<100 DDD 
33  1.24 
(1.02-1.50) 
1.09 
(0.90-1.33) 
1.23 
(1.00-1.51) 
1.23 
(1.01-1.50) 
No 28  1.00 1.00 1.00 1.00 
Model 1 adjusted for age and gender 
Model 2 Model 1 + physical functioning 
Model 3 Model 1 + physical inactivity at phase 1 
Model 4 Model 1 + socioeconomic position, binge drinking, smoking, BMI 
 
Highlights: 
- We demonstrated a longitudinal bidirectional relationship between leisure-time physical 
activity and psychotropic medication 
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- People who are persistently inactive are at increased risk of receiving psychotropic 
medication 
- Increasing amount of psychotropic medication use is associated with subsequent physical 
inactivity 
 
 
